Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Archives of Toxicology|May 24, 2021
CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxicationsAnna Mueller-Schoell, Robin Michelet, Ferdinand Weinelt, et al.
The Journal of Pharmacy and Pharmacology|September 30, 2017
Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistatMd Amin Hossain, Timothy Tran, Tianmeng Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 3, 2008
In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6Johanna Weiss, Evelyn Sawa, Klaus-Dieter Riedel, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 12, 2017
In vitro inhibition of human UGT isoforms by ritonavir and cobicistatSara Algeelani, Novera Alam, Md Amin Hossain, et al.
British Journal of Clinical Pharmacology|August 21, 2014
Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activityAlexandra Carls, Julia Jedamzik, Lukas Witt, et al.
Basic & Clinical Pharmacology & Toxicology|September 17, 2014
Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidineChristine Eichbaum, Kristin Mathes, Jürgen Burhenne, et al.
Pharmaceutics|March 26, 2022
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its MetabolismJosefine Schulz, Antonia Thomas, Ayatallah Saleh, et al.
Clinical Pharmacokinetics|August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical DataFranziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2008
[Telemetry in the clinical setting]Thomas Hilbel, Thomas M Helms, Gerd Mikus, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometryJürgen Burhenne, Klaus Dieter Riedel, Meret Martin-Facklam, et al.
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Archives of Toxicology|May 24, 2021
CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxicationsAnna Mueller-Schoell, Robin Michelet, Ferdinand Weinelt, et al.
The Journal of Pharmacy and Pharmacology|September 30, 2017
Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistatMd Amin Hossain, Timothy Tran, Tianmeng Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 3, 2008
In vitro metabolism of the opioid tilidine and interaction of tilidine and nortilidine with CYP3A4, CYP2C19, and CYP2D6Johanna Weiss, Evelyn Sawa, Klaus-Dieter Riedel, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 12, 2017
In vitro inhibition of human UGT isoforms by ritonavir and cobicistatSara Algeelani, Novera Alam, Md Amin Hossain, et al.
British Journal of Clinical Pharmacology|August 21, 2014
Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activityAlexandra Carls, Julia Jedamzik, Lukas Witt, et al.
Basic & Clinical Pharmacology & Toxicology|September 17, 2014
Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidineChristine Eichbaum, Kristin Mathes, Jürgen Burhenne, et al.
Pharmaceutics|March 26, 2022
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its MetabolismJosefine Schulz, Antonia Thomas, Ayatallah Saleh, et al.
Clinical Pharmacokinetics|August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical DataFranziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2008
[Telemetry in the clinical setting]Thomas Hilbel, Thomas M Helms, Gerd Mikus, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometryJürgen Burhenne, Klaus Dieter Riedel, Meret Martin-Facklam, et al.
Pageof 20